Inventor · disambiguated record
George R. Granneman
Also filed as: GRANNEMAN GEORGE R · GRANNEMAN GEORGE RICHARD
12 granted patents·9 pending applications·138 citations·filing 1982–2020
93Inventor score
Top patents by PatentIndex Score
21 records- 0194US9090689B1Use of TNFα inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Jul 28, 2015·13 cites·21 claims
- 0294US8906373B2Use of TNF-alpha inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 9, 2014·20 cites·9 claims
- 0394US8889136B2Multiple-variable dose regimen for treating TNFα-related disordersHOFFMAN REBECCA S·Filed 2005·Granted Nov 18, 2014·25 cites·18 claims
- 0493US9085620B1Use of TNFα inhibitor for treatment of psoriatic arthritisABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Jul 21, 2015·12 cites·30 claims
- 0593US8986693B1Use of TNFα inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Mar 24, 2015·14 cites·8 claims
- 0693US8961974B2Multiple-variable dose regimen for treating TNFα-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Feb 24, 2015·12 cites·28 claims
- 0793US8961973B2Multiple-variable dose regimen for treating TNFα-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Feb 24, 2015·12 cites·30 claims
- 0892US9187559B2Multiple-variable dose regimen for treating idiopathic inflammatory bowel diseaseABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Nov 17, 2015·8 cites·30 claims
- 0990US9512216B2Use of TNFα inhibitorABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Dec 6, 2016·5 cites·16 claims
- 1090US9499615B2Multiple-variable dose regimen for treating idiopathic inflammatory bowel diseaseABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Nov 22, 2016·5 cites·28 claims
- 1190US9061005B2Multiple-variable dose regimen for treating idiopathic inflammatory bowel diseaseHOFFMAN REBECCA S·Filed 2012·Granted Jun 23, 2015·10 cites·28 claims
- 1277US2021347875A1MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERSABBVIE BIOTECHNOLOGY LTD·Filed 2020·Application pending·0 cites
- 1377US2021347874A1Multiple-variable dose regimen for treating tnfalpha-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2020·Application pending·0 cites
- 1471US2020017580A1Multiple-variable dose regimen for treating tnfalpha-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2019·Application pending·0 cites
- 1568US2019055308A1MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERSABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 1666US2009304682A1Multiple-variable dose regimen for treating TNFa-related disordersHOFFMAN REBECCA S·Filed 2008·Application pending·0 cites
- 1765US2017022271A1Multiple-variable dose regimen for treating tnfalpha-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2016·Application pending·0 cites
- 1861US2017044249A1MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERSABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 1960US2016376360A9Use of TNFalpha InhibitorABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 2045US2015050216A1Uses and Compositions for Treatment of PsoriasisWILLIAN MARY KAYE·Filed 2014·Application pending·0 cites
- 2133US4432985AN-alkylated carboxylic acid derivatives as anti-convulsant agentsABBOTT LAB·Filed 1982·Granted Feb 21, 1984·2 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →